For which conditions is Clonidine indicated according to the FDA label?

Clonidine is primarily indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and hypertension, which aligns with its FDA label.

For ADHD, Clonidine works as a non-stimulant option that can help improve focus, reduce impulsivity, and enhance overall behavioral control in children and adolescents. Its effectiveness in this area makes it a valuable alternative to traditional stimulant medications.

In terms of hypertension, Clonidine primarily acts as an alpha-2 adrenergic agonist, which helps lower blood pressure by decreasing heart rate and relaxing blood vessels. This dual indication makes Clonidine a versatile medication within the therapeutic landscape, particularly in scenarios where patients may have co-occurring ADHD and hypertension.

The other options do not reflect approved indications for Clonidine as noted in the FDA label. Diabetes and hyperlipidemia, asthma and allergies, or insomnia and anxiety are not conditions for which Clonidine is designated as an effective treatment based on its pharmacological profile and clinical applications.